Waldencast SEC Investigation Concludes
Analysis based on 6 articles · First reported Apr 28, 2026 · Last updated Apr 28, 2026
The conclusion of the United States — United States Securities and Exchange Commission investigation without enforcement action is a significant positive for Waldencast, likely leading to increased investor confidence and a positive impact on its stock price. This removes a major regulatory overhang that had been affecting the company.
Waldencast announced that the United States — United States Securities and Exchange Commission has concluded its investigation into the company's restatement of financial results and material weaknesses in internal control over financial reporting, which were related to historical accounting practices used by Obagi Cosmeceuticals. The United States — United States Securities and Exchange Commission does not intend to recommend an enforcement action against Waldencast. Michel Brousset, CEO of Waldencast, expressed pleasure with the favorable outcome, highlighting the company's full cooperation and dedication of resources throughout the investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard